“We are very impressed with Syngene’s professionalism, commitment to scientific excellence, and ability to deliver high-quality work on time,” said Allan Wehnert, CEO & Founder of Orocidin. “This ...

Indian drugmaker Biocon Ltd on Monday appointed Peter Bains ... sold a 9.96% stake in its unit and contract research firm Syngene International through open market sale, it said in an exchange ...

Jonathan Hunt has resigned as Syngene International's MD & CEO, succeeded by Peter Bains who was the company's former CEO.